Scleroderma : The New Boston Study and the Therapy That Can Save Your Life

Similar to skin cancer, and long considered incurable, Scleroderma can be a slow, painful killer. But now there may be new hope for the more than 400,000 Americans afflicted with Scleroderma. Simultaneous with the publication of this book, a leading medical journal will present the results of a landmark clinical trial of the first and only therapy to report reversal and remission of this deadly disease.